,uuid,title,publisher,link,providerPublishTime,type
0,dce3128f-35c4-309c-8ee1-1f61fb6e90d0,"Analyst Report: Charles River Laboratories International, Inc.",Morningstar Research,https://finance.yahoo.com/m/dce3128f-35c4-309c-8ee1-1f61fb6e90d0/analyst-report%3A-charles-river.html,1647990728,STORY
1,096fdd4f-839b-36f3-aabd-cf6de90f9738,Why Is Charles River (CRL) Down 3.4% Since Last Earnings Report?,Zacks,https://finance.yahoo.com/news/why-charles-river-crl-down-153003471.html,1647617403,STORY
2,2c3dcfd6-19fe-317b-9945-ba6a0a83e1dd,"CoDiagnostics, Inc. (CODX) Surges 13.1%: Is This an Indication of Further Gains?",Zacks,https://finance.yahoo.com/news/codiagnostics-inc-codx-surges-13-063006417.html,1647412206,STORY
3,7477763e-8d40-3ae3-ada1-26b1f7d837e1,"The Petri Dish: Moderna changes tune on patents, Alloy invests in peptide startup",American City Business Journals,https://finance.yahoo.com/m/7477763e-8d40-3ae3-ada1-26b1f7d837e1/the-petri-dish%3A-moderna.html,1646908916,STORY
4,ed06902b-2507-3950-b83c-dc5ca0388f5d,Here's Why You Should Retain Charles River (CRL) Stock For Now,Zacks,https://finance.yahoo.com/news/heres-why-retain-charles-river-134801333.html,1646833681,STORY
5,e771a20e-67a1-356a-8431-e75d2655425d,"Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish",Zacks,https://finance.yahoo.com/news/charles-river-crl-dsa-arm-155603271.html,1645545363,STORY
6,7f77a561-0197-3724-b476-e2a1151211a4,Here's Why We Think Charles River Laboratories International (NYSE:CRL) Is Well Worth Watching,Simply Wall St.,https://finance.yahoo.com/news/heres-why-think-charles-river-115522790.html,1645271722,STORY
7,eb16e3d0-267c-35fe-95f3-59c11f24ad1b,Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now,Zacks,https://finance.yahoo.com/news/heres-why-hold-idexx-idxx-131801402.html,1645103881,STORY
